Chadi Saad-Roy was a high school math whiz with no idea when he first enrolled at UVic in 2012 that he would one day be trying to unravel how a cow with cattle fever spreads the disease to the rest of the herd. What a difference five years makes.
Charlotte Loppie, a professor in UVic's School of Public Health and Social Policy and director of the Centre for Indigenous Research and Community-Led Engagement—is one of three Canadian researchers who will be awarded a prestigious Gold Leaf Prize from CIHR at a May 16 ceremony in Ottawa.
What do you do with unimaginable heartbreak? One couple, Mabel and CK Chan, are working to make sure that other parents never experience their loss—and that others’ children are protected from deadly meningitis infections. A UVic immunization campaign kicks off on March 1.
Drugs used to prevent and treat HIV could be contributing to a dramatic rise in syphilis cases, according to a new study co-authored by UVic microbiologist Caroline Cameron. The study suggests that antiretroviral therapy medications for treating HIV may affect the body’s immune response to certain diseases, including syphilis.
Drugs used to prevent and treat HIV could be contributing to a rise in syphilis cases, according to a new study co-authored by a UVic microbiologist.
An international team of scientists co-led by a University of Victoria researcher is one step closer to a vaccine for syphilis. Co-leaders UVic microbiologist Caroline Cameron and University of Washington’s Sheila Lukehart received a $2.3 million grant (USD) from the US National Institute of Allergy and Infectious Diseases at the National Institutes of Health. The grant will allow them to continue to make headway on vaccine development.
The theme of this year’s World Health Day is “Beat diabetes.” About 350 million people worldwide have diabetes and that number is projected to more than double in the next 20 years. Eleven million Canadians are living with the disease, and every thr…
A small six-person team of scientists and lab technicians are leading a global revolution in medical diagnostics—from right here, in Victoria. Healthy or not, all of us at some time have been subjected to one of the most common forms of medial diagnostics—the dreaded blood test. But what if there was a way to avoid this uncomfortable process?
When UVic engineering professor Dr. Reuven Gordon describes the biomedical engineering technique of listening to and recording the “voice” of proteins, it sounds a lot like a modern take on Horton Hears a Who, Dr. Seuss’s children’s story of an elephant who hears a voice calling from a microscopic dust speck. “Everything small has resonances. Everything has a voice,” Gordon says of the protein molecules measuring a single nanometer in size—the building blocks of life that are a million times smaller than an ant and emit sound at a frequency a million times higher than the human ear can hear.
It certainly sounds novel: could a smelling test, easy enough to administer to young children, help diagnose Fetal Alcohol Spectrum Disorder (FASD)? That possibility is taking shape, thanks to work done by UVic neuroscience PhD student Christine Fontaine.
A newly published study from the University of Victoria’s Centre for Addictions Research of BC (CARBC) confirms that moderate drinkers have an increased risk of breast cancer. The study shows that consuming an average of up to two drinks a day is
September is World Alzheimer’s Month. By 2031, 25 per cent of BC’s population will be at increased risk of dementia due to old age. How can we make our urban spaces more accessible and convenient for people with dementia? University of Victoria grad…
The most effective vaccines against disease are those that expose our immune systems to live pathogens. But how do we do that without causing the very disease we’re trying to avoid?
Chemistry professor Dr. Frank van Veggel likes to work with extremely small particles and very big ideas. He’s developed a process whereby nanoparticles, each 10 times smaller than a speck of dust, could someday assist oncologists better identify and target cancerous tumours and, in some cases, eliminate the need for painful and potentially dangerous biopsies.
A new process developed at the University of Victoria that will help oncologists better identify and target cancerous tumours has been granted a US patent.
A University of Victoria post-doctoral student’s efforts to help people with learning and memory problems related to Alzheimer’s disease and cognitive disorders have earned her a $50,000 award. Celina Berg will also have access to office and lab spa…
